US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anti-Venom market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anti-Venom market." Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection. The global Anti-Venom market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Anti-Venom volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Venom market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Medtoxin Venom Laboratories Institute of Immunology Alomone Labs Sigma Aldrich Wyeth Pharmaceuticals Protherics PLC Bharat Serums and Vaccines Butantan Institute Haffkine Bio-Pharmaceutical Corporation Micropaharm Limited Segment by Regions North America Europe China Japan Segment by Type Cytotoxic Neurotoxic Haemotoxic Cardiotoxic Myotoxic Segment by Application Snake Spider Scorpion
Table of Contents Executive Summary 1 Anti-Venom Market Overview 1.1 Product Overview and Scope of Anti-Venom 1.2 Anti-Venom Segment by Type 1.2.1 Global Anti-Venom Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Cytotoxic 1.2.3 Neurotoxic 1.2.4 Haemotoxic 1.2.5 Cardiotoxic 1.2.6 Myotoxic 1.3 Anti-Venom Segment by Application 1.3.1 Anti-Venom Consumption Comparison by Application (2014-2025) 1.3.2 Snake 1.3.3 Spider 1.3.4 Scorpion 1.4 Global Anti-Venom Market by Region 1.4.1 Global Anti-Venom Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Anti-Venom Market Size 1.5.1 Global Anti-Venom Revenue (2014-2025) 1.5.2 Global Anti-Venom Production (2014-2025) 2 Global Anti-Venom Market Competition by Manufacturers 2.1 Global Anti-Venom Production Market Share by Manufacturers (2014-2019) 2.2 Global Anti-Venom Revenue Share by Manufacturers (2014-2019) 2.3 Global Anti-Venom Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Anti-Venom Production Sites, Area Served, Product Types 2.5 Anti-Venom Market Competitive Situation and Trends 2.5.1 Anti-Venom Market Concentration Rate 2.5.2 Anti-Venom Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Anti-Venom Production Market Share by Regions 3.1 Global Anti-Venom Production Market Share by Regions 3.2 Global Anti-Venom Revenue Market Share by Regions (2014-2019) 3.3 Global Anti-Venom Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Anti-Venom Production 3.4.1 North America Anti-Venom Production Growth Rate (2014-2019) 3.4.2 North America Anti-Venom Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Anti-Venom Production 3.5.1 Europe Anti-Venom Production Growth ... | read more...